Nasus Pharma Ltd. financial statements
Nasus Pharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 1.24B | 20-F |
| Net income | −USD 5.86M | 20-F |
| Cash and equivalents | USD 1.24M | 20-F |
| Total debt | USD 118K | EODHD |
Nasus Pharma Ltd. financials on 6ix · Nasus Pharma Ltd. on 6ix